Extension of Approval for Stelara® (Ustekinumab) for the Treatment of Ulcerative colitis

被引:0
|
作者
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:399 / 399
页数:1
相关论文
共 50 条
  • [21] Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis
    Sands, B. E.
    Sandborn, W. J.
    Panaccione, R.
    O'Brien, C. D.
    Zhang, H.
    Johanns, J.
    Adedokun, O. J.
    Li, K.
    Peyrin-Biroulet, L.
    Van Assche, G.
    Danese, S.
    Targan, S.
    Abreu, M. T.
    Hisamatsu, T.
    Szapary, P.
    Marano, C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (13): : 1201 - 1214
  • [22] Ustekinumab as an opportunity for refractory Ulcerative Colitis patients
    Iborra, M.
    Soutullo, C.
    Gimeno, M.
    Bastida, G.
    Aguas, M.
    Cerrillo, E.
    Saez-Gonzalez, E.
    Garrido, A.
    Minguez, A.
    Bordetas, J.
    Nos, P.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I383 - I384
  • [23] Ustekinumab for treating ulcerative colitis: an expert opinion
    Biancone, Livia
    Ardizzone, Sandro
    Armuzzi, Alessandro
    Castiglione, Fabiana
    D'Inca, Renata
    Danese, Silvio
    Daperno, Marco
    Gionchetti, Paolo
    Rizzello, Fernando
    Scribano, Maria Lia
    Vecchi, Maurizio
    Orlando, Ambrogio
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (11) : 1321 - 1329
  • [25] Wezlana - An Ustekinumab Biosimilar Interchangeable with Stelara
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2024, 66 (1707):
  • [26] USTEKINUMAB FOR THE TREATMENT OF MODERATE TO SEVERE ULCERATIVE COLITIS: A MULTICENTRE UK COHORT STUDY
    Al-Hillawi, Lulia
    Honap, Sailish
    Baillie, Samantha
    Bancil, Aaron
    Kok, Klaartje
    Patel, Kamal
    Walsh, Alissa
    Irving, Peter
    Samaan, Mark
    GUT, 2022, 71 : A36 - A37
  • [27] Paradoxical ulcerative colitis during adalimumab treatment of psoriasis resolved by switch to ustekinumab
    Kolios, A. G. A.
    Biedermann, L.
    Weber, A.
    Navarini, A. A.
    Meier, J.
    Cozzio, A.
    French, L. E.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 178 (02) : 551 - 555
  • [28] Effectiveness and Persistency of Ustekinumab Treatment for Ulcerative Colitis: A Phoenix retrospective Cohort Study
    Ando, Katsuyoshi
    Fujiya, Mikihiro
    Ueno, Nobuhiro
    Ito, Takahiro
    Maemoto, Atsuo
    Nasuno, Masanao
    Tanaka, Hiroki
    Sakurai, Kensuke
    Katsurada, Takehiko
    Orii, Fumika
    Ashida, Toshifumi
    Motoya, Satoshi
    Kazama, Tomoe
    Yokoyama, Yoshihiro
    Hirayama, Daisuke
    Nakase, Hiroshi
    CROHNS & COLITIS 360, 2024, 6 (02)
  • [29] Real-world data on outcomes of treatment with ustekinumab in patients with Ulcerative Colitis
    Chalakatevaki, K.
    Kokkotis, G.
    Chatzinikolaou, M. L.
    Anagnostopoulou, E.
    Argiriou, K.
    Viazis, N.
    Galanopoulos, M.
    Gerasimatos, G.
    Giouleme, O.
    Zampeli, E.
    Zacharopoulou, E.
    Theodoropoulou, A.
    Theocharis, G.
    Kalogirou, M.
    Karatzas, P.
    Karmiris, K.
    Kapsoritakis, A.
    Koustenis, K.
    Koutroumpakis, I.
    Kiriakos, N.
    Lazou, D.
    Liatsos, C.
    Mantaka, A.
    Mantzaris, G.
    Michalopoulos, G.
    Michopoulos, S.
    Orfanidou, A.
    Papathanasiou, E.
    Polymeros, D.
    Potamianos, S.
    Sotiropoulos, C.
    Soufleris, K.
    Tzouvala, M.
    Foteinogiannopoulou, K.
    Chatzidakis, A.
    Psistakis, A.
    Bamias, G.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1705 - I1706
  • [30] Ustekinumab (Stelara) for Crohn's Disease
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2017, 59 (1511): : 5 - 6